Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy

· Affiliated Hospital to Academy of Military Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma [EARLY_Phase 1]

See pricing